Course and treatment of perianal disease in children newly diagnosed with Crohn's disease

David J. Keljo, James Markowitz, Christine Langton, Trudy Lerer, Athos Bousvaros, Ryan Carvalho, Wallace Crandall, Jonathan Evans, Anne Griffiths, Marsha Kay, Subra Kugathasan, Neil LeLeiko, David Mack, Petar Mamula, M. Susan Moyer, Maria Oliva-Hemker, Anthony Otley, Marian Pfefferkorn, Joel Rosh, Jeffrey S. Hyams

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Background: We sought to characterize perianal disease and its treatment in pediatric patients newly diagnosed with Crohn's disease. Methods: Data were obtained from the Pediatric Inflammatory Bowel Disease (IBD) Collaborative Group Registry, a prospective, multicenter observational registry recording clinical and laboratory outcomes in children under 16 years of age newly diagnosed with IBD. Patients with Crohn's disease were selected who had data on perianal disease and at least 24 months of follow-up. The records of patients with a Pediatric Crohn's Disease Activity Index perianal subscore greater than 0 were reviewed, and patients with abscesses or fistulas were selected. The therapies used and the course of their perianal disease were then assessed. Results: Of the 276 patients identified, 41 had perianal lesions within 30 days of diagnosis. Thirteen of these had skin tags and fissures only, whereas 28 had fistulas and/or abscesses. The latter lesions resolved by 1 year in 20 patients, and 8 had chronic/recurrent perianal disease persisting for more than 1 year following diagnosis. Patients with fistulizing disease were much more likely to be treated and were treated earlier with antibiotics, infliximab, and immunomodulators than were nonfistulizing patients. Patients who developed chronic perianal disease were more likely to have low body mass indices and required more perianal surgery than did patients whose perianal disease resolved. Conclusions: Approximately 10% of newly diagnosed pediatric patients with Crohn's disease will have perianal fistulas and/or abscesses at the time of diagnosis. Most of these will resolve within a year with medical therapy alone.

Original languageEnglish (US)
Pages (from-to)383-387
Number of pages5
JournalInflammatory bowel diseases
Volume15
Issue number3
DOIs
StatePublished - Jul 17 2009
Externally publishedYes

Fingerprint

Crohn Disease
Therapeutics
Abscess
Fistula
Pediatrics
Inflammatory Bowel Diseases
Registries
Immunologic Factors
Body Mass Index
Chronic Disease
Anti-Bacterial Agents
Skin

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Gastroenterology

Cite this

Keljo, D. J., Markowitz, J., Langton, C., Lerer, T., Bousvaros, A., Carvalho, R., ... Hyams, J. S. (2009). Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflammatory bowel diseases, 15(3), 383-387. https://doi.org/10.1002/ibd.20767
Keljo, David J. ; Markowitz, James ; Langton, Christine ; Lerer, Trudy ; Bousvaros, Athos ; Carvalho, Ryan ; Crandall, Wallace ; Evans, Jonathan ; Griffiths, Anne ; Kay, Marsha ; Kugathasan, Subra ; LeLeiko, Neil ; Mack, David ; Mamula, Petar ; Moyer, M. Susan ; Oliva-Hemker, Maria ; Otley, Anthony ; Pfefferkorn, Marian ; Rosh, Joel ; Hyams, Jeffrey S. / Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. In: Inflammatory bowel diseases. 2009 ; Vol. 15, No. 3. pp. 383-387.
@article{fb579a3807594077a350d5848fb0c236,
title = "Course and treatment of perianal disease in children newly diagnosed with Crohn's disease",
abstract = "Background: We sought to characterize perianal disease and its treatment in pediatric patients newly diagnosed with Crohn's disease. Methods: Data were obtained from the Pediatric Inflammatory Bowel Disease (IBD) Collaborative Group Registry, a prospective, multicenter observational registry recording clinical and laboratory outcomes in children under 16 years of age newly diagnosed with IBD. Patients with Crohn's disease were selected who had data on perianal disease and at least 24 months of follow-up. The records of patients with a Pediatric Crohn's Disease Activity Index perianal subscore greater than 0 were reviewed, and patients with abscesses or fistulas were selected. The therapies used and the course of their perianal disease were then assessed. Results: Of the 276 patients identified, 41 had perianal lesions within 30 days of diagnosis. Thirteen of these had skin tags and fissures only, whereas 28 had fistulas and/or abscesses. The latter lesions resolved by 1 year in 20 patients, and 8 had chronic/recurrent perianal disease persisting for more than 1 year following diagnosis. Patients with fistulizing disease were much more likely to be treated and were treated earlier with antibiotics, infliximab, and immunomodulators than were nonfistulizing patients. Patients who developed chronic perianal disease were more likely to have low body mass indices and required more perianal surgery than did patients whose perianal disease resolved. Conclusions: Approximately 10{\%} of newly diagnosed pediatric patients with Crohn's disease will have perianal fistulas and/or abscesses at the time of diagnosis. Most of these will resolve within a year with medical therapy alone.",
author = "Keljo, {David J.} and James Markowitz and Christine Langton and Trudy Lerer and Athos Bousvaros and Ryan Carvalho and Wallace Crandall and Jonathan Evans and Anne Griffiths and Marsha Kay and Subra Kugathasan and Neil LeLeiko and David Mack and Petar Mamula and Moyer, {M. Susan} and Maria Oliva-Hemker and Anthony Otley and Marian Pfefferkorn and Joel Rosh and Hyams, {Jeffrey S.}",
year = "2009",
month = "7",
day = "17",
doi = "10.1002/ibd.20767",
language = "English (US)",
volume = "15",
pages = "383--387",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

Keljo, DJ, Markowitz, J, Langton, C, Lerer, T, Bousvaros, A, Carvalho, R, Crandall, W, Evans, J, Griffiths, A, Kay, M, Kugathasan, S, LeLeiko, N, Mack, D, Mamula, P, Moyer, MS, Oliva-Hemker, M, Otley, A, Pfefferkorn, M, Rosh, J & Hyams, JS 2009, 'Course and treatment of perianal disease in children newly diagnosed with Crohn's disease', Inflammatory bowel diseases, vol. 15, no. 3, pp. 383-387. https://doi.org/10.1002/ibd.20767

Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. / Keljo, David J.; Markowitz, James; Langton, Christine; Lerer, Trudy; Bousvaros, Athos; Carvalho, Ryan; Crandall, Wallace; Evans, Jonathan; Griffiths, Anne; Kay, Marsha; Kugathasan, Subra; LeLeiko, Neil; Mack, David; Mamula, Petar; Moyer, M. Susan; Oliva-Hemker, Maria; Otley, Anthony; Pfefferkorn, Marian; Rosh, Joel; Hyams, Jeffrey S.

In: Inflammatory bowel diseases, Vol. 15, No. 3, 17.07.2009, p. 383-387.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Course and treatment of perianal disease in children newly diagnosed with Crohn's disease

AU - Keljo, David J.

AU - Markowitz, James

AU - Langton, Christine

AU - Lerer, Trudy

AU - Bousvaros, Athos

AU - Carvalho, Ryan

AU - Crandall, Wallace

AU - Evans, Jonathan

AU - Griffiths, Anne

AU - Kay, Marsha

AU - Kugathasan, Subra

AU - LeLeiko, Neil

AU - Mack, David

AU - Mamula, Petar

AU - Moyer, M. Susan

AU - Oliva-Hemker, Maria

AU - Otley, Anthony

AU - Pfefferkorn, Marian

AU - Rosh, Joel

AU - Hyams, Jeffrey S.

PY - 2009/7/17

Y1 - 2009/7/17

N2 - Background: We sought to characterize perianal disease and its treatment in pediatric patients newly diagnosed with Crohn's disease. Methods: Data were obtained from the Pediatric Inflammatory Bowel Disease (IBD) Collaborative Group Registry, a prospective, multicenter observational registry recording clinical and laboratory outcomes in children under 16 years of age newly diagnosed with IBD. Patients with Crohn's disease were selected who had data on perianal disease and at least 24 months of follow-up. The records of patients with a Pediatric Crohn's Disease Activity Index perianal subscore greater than 0 were reviewed, and patients with abscesses or fistulas were selected. The therapies used and the course of their perianal disease were then assessed. Results: Of the 276 patients identified, 41 had perianal lesions within 30 days of diagnosis. Thirteen of these had skin tags and fissures only, whereas 28 had fistulas and/or abscesses. The latter lesions resolved by 1 year in 20 patients, and 8 had chronic/recurrent perianal disease persisting for more than 1 year following diagnosis. Patients with fistulizing disease were much more likely to be treated and were treated earlier with antibiotics, infliximab, and immunomodulators than were nonfistulizing patients. Patients who developed chronic perianal disease were more likely to have low body mass indices and required more perianal surgery than did patients whose perianal disease resolved. Conclusions: Approximately 10% of newly diagnosed pediatric patients with Crohn's disease will have perianal fistulas and/or abscesses at the time of diagnosis. Most of these will resolve within a year with medical therapy alone.

AB - Background: We sought to characterize perianal disease and its treatment in pediatric patients newly diagnosed with Crohn's disease. Methods: Data were obtained from the Pediatric Inflammatory Bowel Disease (IBD) Collaborative Group Registry, a prospective, multicenter observational registry recording clinical and laboratory outcomes in children under 16 years of age newly diagnosed with IBD. Patients with Crohn's disease were selected who had data on perianal disease and at least 24 months of follow-up. The records of patients with a Pediatric Crohn's Disease Activity Index perianal subscore greater than 0 were reviewed, and patients with abscesses or fistulas were selected. The therapies used and the course of their perianal disease were then assessed. Results: Of the 276 patients identified, 41 had perianal lesions within 30 days of diagnosis. Thirteen of these had skin tags and fissures only, whereas 28 had fistulas and/or abscesses. The latter lesions resolved by 1 year in 20 patients, and 8 had chronic/recurrent perianal disease persisting for more than 1 year following diagnosis. Patients with fistulizing disease were much more likely to be treated and were treated earlier with antibiotics, infliximab, and immunomodulators than were nonfistulizing patients. Patients who developed chronic perianal disease were more likely to have low body mass indices and required more perianal surgery than did patients whose perianal disease resolved. Conclusions: Approximately 10% of newly diagnosed pediatric patients with Crohn's disease will have perianal fistulas and/or abscesses at the time of diagnosis. Most of these will resolve within a year with medical therapy alone.

UR - http://www.scopus.com/inward/record.url?scp=66149091590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149091590&partnerID=8YFLogxK

U2 - 10.1002/ibd.20767

DO - 10.1002/ibd.20767

M3 - Article

VL - 15

SP - 383

EP - 387

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 3

ER -

Keljo DJ, Markowitz J, Langton C, Lerer T, Bousvaros A, Carvalho R et al. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflammatory bowel diseases. 2009 Jul 17;15(3):383-387. https://doi.org/10.1002/ibd.20767